Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Indolyl-naphthyl-maleimides as potent and selective inhibitors of protein kinase C-α/β.

van Eis MJ, Evenou J, Schuler W, Zenke G, Vangrevelinghe E, Wagner J, von Matt P.

Bioorg Med Chem Lett. 2017 Feb 15;27(4):781-786. doi: 10.1016/j.bmcl.2017.01.038. Epub 2017 Jan 16.

PMID:
28131714
2.

Discovery and profiling of a selective and efficacious Syk inhibitor.

Thoma G, Smith AB, van Eis MJ, Vangrevelinghe E, Blanz J, Aichholz R, Littlewood-Evans A, Lee CC, Liu H, Zerwes HG.

J Med Chem. 2015 Feb 26;58(4):1950-63. doi: 10.1021/jm5018863. Epub 2015 Feb 9.

PMID:
25633741
3.

Novel ROCK inhibitors for the treatment of pulmonary arterial hypertension.

Shaw D, Hollingworth G, Soldermann N, Sprague E, Schuler W, Vangrevelinghe E, Duggan N, Thomas M, Kosaka T, Waters N, van Eis MJ.

Bioorg Med Chem Lett. 2014 Oct 15;24(20):4812-7. doi: 10.1016/j.bmcl.2014.09.002. Epub 2014 Sep 6.

PMID:
25248678
4.

2,6-Naphthyridines as potent and selective inhibitors of the novel protein kinase C isozymes.

van Eis MJ, Evenou JP, Floersheim P, Gaul C, Cowan-Jacob SW, Monovich L, Rummel G, Schuler W, Stark W, Strauss A, von Matt A, Vangrevelinghe E, Wagner J, Soldermann N.

Bioorg Med Chem Lett. 2011 Dec 15;21(24):7367-72. doi: 10.1016/j.bmcl.2011.10.025. Epub 2011 Oct 21.

PMID:
22078216
5.

7,14-Dichloro[1.1]metacyclophane: A Highly Strained Aromatic Intermediate.

van Eis MJ, de Kanter FJ, de Wolf WH, Bickelhaupt F.

J Org Chem. 1997 Oct 17;62(21):7090-7091. No abstract available.

PMID:
11671807
6.

Dichlorocarbene Addition to

van Eis MJ, van Der Linde BS, de Kanter FJ, de Wolf WH, Bickelhaupt F.

J Org Chem. 2000 Jul 14;65(14):4348-4354.

PMID:
10891137
7.

Hydrogenation of

van Eis MJ, Wijsman GW, de Wolf WH, Bickelhaupt F, Rogers DW, Kooijman H, Spek AL.

Chemistry. 2000 May 2;6(9):1537-46.

PMID:
10839170
8.

1,4-Addition of a Terminal Phosphinidene Complex to [5]Metacyclophane.

van Eis MJ, Komen CMD, de Kanter FJJ, de Wolf WH, Lammertsma K, Bickelhaupt F, Lutz M, Spek AL.

Angew Chem Int Ed Engl. 1998 Jun 19;37(11):1547-1550. doi: 10.1002/(SICI)1521-3773(19980619)37:11<1547::AID-ANIE1547>3.0.CO;2-S.

PMID:
29710922
9.

Nonsteroidal-induced benign strictures of the colon: a case report and review of the literature.

Eis MJ, Watkins BM, Philip A, Welling RE.

Am J Gastroenterol. 1998 Jan;93(1):120-1.

PMID:
9448192
10.

Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated.

Diebold RJ, Eis MJ, Yin M, Ormsby I, Boivin GP, Darrow BJ, Saffitz JE, Doetschman T.

Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12215-9.

11.

Onset and progression of pathological lesions in transforming growth factor-beta 1-deficient mice.

Boivin GP, O'Toole BA, Orsmby IE, Diebold RJ, Eis MJ, Doetschman T, Kier AB.

Am J Pathol. 1995 Jan;146(1):276-88.

12.

Effectiveness of natural and synthetic complexes of porin and O polysaccharide as vaccines against Brucella abortus in mice.

Winter AJ, Rowe GE, Duncan JR, Eis MJ, Widom J, Ganem B, Morein B.

Infect Immun. 1988 Nov;56(11):2808-17.

13.

An improved synthesis of D-perosamine and some derivatives.

Eis MJ, Ganem B.

Carbohydr Res. 1988 May 15;176(2):316-23. No abstract available.

PMID:
3138026

Supplemental Content

Support Center